Numerous studies have shown that PTP1B is an important target for antitumor therapy and is closely related to the occurrence and development of breast cancer, liver cancer, colon cancer, non-small cell lung cancer, prostate cancer, and pancreatic cancer (Kostrzewa et al., 2019). Here, PTPN1 is linked to prostate carcinoma.